Study Finds Weight Loss Drug Semaglutide May Slow Biological Aging
A recent study has revealed that semaglutide, a popular weight loss drug, may have the potential to slow biological aging. Conducted on 108 adults with HIV-associated lipohypertrophy, the study found that participants receiving semaglutide injections showed slower aging patterns across several epigenetic clocks. These clocks are linked to inflammation and major organ systems such as the heart, brain, kidneys, liver, and metabolic system. The pace of biological aging was reduced by about 9% according to the DunedinPACE epigenetic clock. The findings suggest that semaglutide could have broader implications beyond its current use, potentially benefiting the general population by reducing age-related disease risks. 
